Aβ protofibril binding antibodies
US9573994B2 · kind B2 · utility
2Cited by
27References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 8, 2015 |
| Grant date | Feb 21, 2017 |
| Priority date | — |
| Expiry date | Jul 8, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the amyloid beta peptide (Aβ) and more specifically to antibodies binding to Aβ protofibrils and their use in therapy and/or prophylactic treatment of Alzheimer's disease and other disorders associated with Aβ protein aggregation. Further the invention may relate to diagnosis of such diseases as well as monitoring of disease progression by use of the antibodies of the invention. Further, the invention may relate to veterinary use of the antibodies of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.